Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia.
Saved in:
| Title: | Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia. |
|---|---|
| Authors: | Amatya C; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA., Weissler KA; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA., Fellowes V; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD, USA., Lam N; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA., Cutmore LC; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA., Natrakul DA; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA., Highfill SL; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD, USA., Kochenderfer JN; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA. |
| Source: | Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Feb 13; Vol. 32 (1), pp. 101212. Date of Electronic Publication: 2024 Feb 13 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101624857 Publication Model: eCollection Cited Medium: Print ISSN: 2329-0501 (Print) Linking ISSN: 23290501 NLM ISO Abbreviation: Mol Ther Methods Clin Dev Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38455264 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Amatya+C%22">Amatya C</searchLink>; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Weissler+KA%22">Weissler KA</searchLink>; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fellowes+V%22">Fellowes V</searchLink>; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lam+N%22">Lam N</searchLink>; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Cutmore+LC%22">Cutmore LC</searchLink>; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Natrakul+DA%22">Natrakul DA</searchLink>; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Highfill+SL%22">Highfill SL</searchLink>; Center for Cellular Engineering, Department of Transfusion Medicine, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kochenderfer+JN%22">Kochenderfer JN</searchLink>; National Institutes of Health, National Cancer Institute, Center for Cancer Research, Surgery Branch Bethesda, Bethesda, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101624857%22">Molecular therapy. Methods & clinical development</searchLink> [Mol Ther Methods Clin Dev] 2024 Feb 13; Vol. 32 (1), pp. 101212. <i>Date of Electronic Publication: </i>2024 Feb 13 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101624857 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2329-0501 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223290501%22">23290501 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Methods Clin Dev <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38455264 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.omtm.2024.101212 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101212 Titles: – TitleFull: Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Amatya C – PersonEntity: Name: NameFull: Weissler KA – PersonEntity: Name: NameFull: Fellowes V – PersonEntity: Name: NameFull: Lam N – PersonEntity: Name: NameFull: Cutmore LC – PersonEntity: Name: NameFull: Natrakul DA – PersonEntity: Name: NameFull: Highfill SL – PersonEntity: Name: NameFull: Kochenderfer JN IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 02 Text: 2024 Feb 13 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 2329-0501 Numbering: – Type: volume Value: 32 – Type: issue Value: 1 Titles: – TitleFull: Molecular therapy. Methods & clinical development Type: main |
| ResultId | 1 |
